{"schema_version":"secwatch.filing_event.v1","accession":"0001232524-25-000073","form_type":"8-K","ticker":"JAZZ","cik":"0001232524","company_name":"Jazz Pharmaceuticals plc","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.986164+00:00","generated_at":"2026-05-17T00:11:58.185659+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Jazz Pharma Q3 rev $1.13B (+7%), GAAP EPS $4.08, adj. EPS $8.13; FY25 rev guid narrowed","bullets":["Total revenues $1.126B (+7% YoY); GAAP net income $251M, non-GAAP adj. net income $501M.","Epidiolex sales grew 20% to $302.6M; Xywav sales grew 11% to $431.4M; Modeyso launch contributed $11.0M.","Zepzelca + atezolizumab combo approved for 1L maintenance ES-SCLC; NCCN inclusion.","Saniona licensing agreement for SAN2355, a Kv7.2/7.3 activator for epilepsy and other indications.","FY2025 total revenue guidance narrowed to $4.175-$4.275B from $4.150-$4.300B."],"urls":{"canonical":"https://secwatch.observer/filing/0001232524-25-000073","json":"https://secwatch.observer/filing/0001232524-25-000073.json","markdown":"https://secwatch.observer/filing/0001232524-25-000073.md","text":"https://secwatch.observer/filing/0001232524-25-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1232524/000123252425000073/0001232524-25-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1232524/000123252425000073/jazz-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:11:58.185659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001104659-26-068983","ticker":"GMRS","company_name":"GMR Solutions Inc.","filed_at":"2026-06-01T20:45:55+00:00","headline":"GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068983","json":"https://secwatch.observer/filing/0001104659-26-068983.json","markdown":"https://secwatch.observer/filing/0001104659-26-068983.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/0001104659-26-068983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1898718/000110465926068983/gmrs-20260601x8k.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039474","ticker":"CRDO","company_name":"Credo Technology Group Holding Ltd","filed_at":"2026-06-01T20:08:16+00:00","headline":"Credo Q4 revenue $437M (+157% YoY); guides Q1 $465-475M; CEO awarded 1.44M performance-based RSUs","event_type":"earnings","sec_items":["2.02","5.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039474","json":"https://secwatch.observer/filing/0001628280-26-039474.json","markdown":"https://secwatch.observer/filing/0001628280-26-039474.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1807794/000162828026039474/0001628280-26-039474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1807794/000162828026039474/crdo-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039379","ticker":null,"company_name":"DAVEY TREE EXPERT CO","filed_at":"2026-06-01T17:50:11+00:00","headline":"Davey Tree Q1 net loss widens to $10.7M; revenue flat at $435.8M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039379","json":"https://secwatch.observer/filing/0001628280-26-039379.json","markdown":"https://secwatch.observer/filing/0001628280-26-039379.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/277638/000162828026039379/0001628280-26-039379-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/277638/000162828026039379/davey-20260528.htm"},"side_by_side_evidence":null},{"accession":"0001437749-26-018927","ticker":"RMCF","company_name":"Rocky Mountain Chocolate Factory, Inc.","filed_at":"2026-06-01T13:15:11+00:00","headline":"Rocky Mountain Chocolate Factory Q4 revenue down 24% to $6.8M; net loss per share widens to $0.38","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018927","json":"https://secwatch.observer/filing/0001437749-26-018927.json","markdown":"https://secwatch.observer/filing/0001437749-26-018927.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616262/000143774926018927/0001437749-26-018927-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616262/000143774926018927/rmcfd20260531_8k.htm"},"side_by_side_evidence":null},{"accession":"0001571123-26-000077","ticker":"SAIC","company_name":"Science Applications International Corp","filed_at":"2026-06-01T10:55:23+00:00","headline":"SAIC Q1 adj EPS $3.23 beats $1.92; raises FY adj EBITDA and EPS guidance","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001571123-26-000077","json":"https://secwatch.observer/filing/0001571123-26-000077.json","markdown":"https://secwatch.observer/filing/0001571123-26-000077.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1571123/000157112326000077/0001571123-26-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1571123/000157112326000077/saic-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001520138-26-000196","ticker":"FNGR","company_name":"FingerMotion, Inc.","filed_at":"2026-05-29T21:12:33+00:00","headline":"FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001520138-26-000196","json":"https://secwatch.observer/filing/0001520138-26-000196.json","markdown":"https://secwatch.observer/filing/0001520138-26-000196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1602409/000152013826000196/0001520138-26-000196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1602409/000152013826000196/fngr-05292026_8k.htm"},"side_by_side_evidence":null},{"accession":"0000885245-26-000025","ticker":"BKE","company_name":"BUCKLE INC","filed_at":"2026-05-29T19:38:39+00:00","headline":"Buckle Q1 net income $46.9M ($0.93/share), sales up 6.1% to $288.7M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000885245-26-000025","json":"https://secwatch.observer/filing/0000885245-26-000025.json","markdown":"https://secwatch.observer/filing/0000885245-26-000025.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/885245/000088524526000025/0000885245-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885245/000088524526000025/bke-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-062458","ticker":"HIND","company_name":"Vyome Holdings, Inc","filed_at":"2026-05-29T12:42:42+00:00","headline":"Vyome Q1 net loss $963K, cash $8.8M, inks JAK inhibitor licensing deal with Impetis","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062458","json":"https://secwatch.observer/filing/0001213900-26-062458.json","markdown":"https://secwatch.observer/filing/0001213900-26-062458.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/0001213900-26-062458-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000121390026062458/ea0292643-8k_vyome.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}